// App-Quantinova.ai

11042 : Evaluation of prevalence, number, and temporal changes of circulating tumor cells as assessed after 2 and 5 years of follow-up in patients with early breast cancer in the SUCCESS A study.

Researchers

Presenter

  • Emanuel C. A. Bauer

Principal Investigators

  • Julia Katharina Neugebauer

  • Ulrich Andergassen

  • Mahdi Rezai

  • Elisabeth Thurner-Herrmanns

  • Andreas Schneeweiss

  • Matthias W. Beckmann

  • Klaus Pantel

  • Wolfgang Janni

  • Brigitte Kathrin Rack

  • Bernadette Jaeger

  • Julia Kathrin Jueckstock

  • Peter A. Fasching

  • Lothar Haeberle

  • Thomas W. P. Friedl

  • Iris Schrader

  • Andreas Lorenz

  • Hans Tesch

Medical Centers

  • Department of Gynecology and Obstetrics University Ulm, Ulm, Germany

  • Breast Center Duesseldorf, Louisen Hospital, Dusseldorf, Germany

  • Gynaekolog-Onkolog. Gem.Praxis, Hannover, Germany

  • Department of Gynecology and Obstetrics University Ulm, Ulm, Germany

  • University Clinic Heidelberg, Heidelberg, Germany

  • Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus, Frankfurt/Main, Germany

  • Frauenklinik Innenstadt Munich University, Muenchen, Germany

  • Department of Biometry/Epidemiology, Erlangen, Germany

  • Department of Gynecology and Obstetrics University Ulm, Ulm, Germany

  • Facharztpraxis Lorenz, Hildburghausen, Germany

  • Department of Gynecology and Obstetrics Ludwig-MaximiliansUniversity, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Fluorouracil

  • Adrucil injection

  • Gemcitabine

  • Zolendronic acid

  • Epirubicin

  • Docetaxel

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved